The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885) - Wittkowski H; Kuemmerle-Deschner JB; Gramlich K; Tzaribachev N; Felix SD; Jung T; Roth J; Rordorf C; Foell D (BMC, 2008)